Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Regulatory Toxicology and Pharmacology : RTP|August 20, 2019
Safety Evaluation of PQ Birch Allergy Immunotherapy to Support Product DevelopmentPaul Baldrick, James W Hutchings, Matthew D Heath, et al.
The World Allergy Organization Journal|November 27, 2019
Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapySviatlana Starchenka, Matthew D Heath, Alyson Lineberry, et al.
Immunity, Inflammation and Disease|November 18, 2014
A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacyAlbert Roger, Nathalie Depreux, Yani Jurgens, et al.
Journal of Applied Toxicology : JAT|June 25, 2019
New toxicity testing of PQ grass allergy immunotherapy to support product developmentPaul Baldrick, James W Hutchings, Matthew D Heath, et al.
Expert Review of Clinical Immunology|February 7, 2017
Clinical use of adjuvants in allergen-immunotherapyLudger Klimek, Carsten B Schmidt-Weber, Matthias F Kramer, et al.
Immunotherapy|July 9, 2016
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up reportAlbert Roger, Nathalie Depreux, Yanina Jurgens, et al.
FEBS Letters|November 6, 2004
Interaction of calmodulin with the phosphofructokinase target sequenceStephen R Martin, Rodolfo R Biekofsky, Murray A Skinner, et al.
Journal for Immunotherapy of Cancer|September 13, 2022
In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanomaMona O Mohsen, Matthew Heath, Matthias F Kramer, et al.
Pageof 3